Mustafa Yıldırım

37PUBLICATIONS
131CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursNutrigenomics and personalised nutrition
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (37)

|Jun 26, 2026
Early PSA Decline Predicts Survival Outcomes in Metastatic Castration-Resistant Prostate Cancer Treated with Androgen Receptor Pathway Inhibitors: A Retrospective Single-Center Study.

|Jun 26, 2026
Prognostic Value of C-Reactive Protein-Albumin-Lymphocyte (CALLY) Index for Survival in Nivolumab-Treated Metastatic Renal Cell Carcinoma.

|Jun 25, 2026
Clinical and Social Determinants of Treatment Adherence in Cancer Patients: The Contributory Role of Hearing Loss.

|May 27, 2026
First-Line Treatment After Perioperative FLOT in Recurrent Gastric and Gastroesophageal Junction Cancer: A Turkish Oncology Group (TOG) Multicenter Real-World Analysis.

|May 27, 2026
Prognostic Role of Uric Acid-to-Albumin Ratio in Patients with Metastatic Breast Cancer Treated with CDK4/6 Inhibitors.

|Apr 01, 2026
Clinical impact of TP53 mutation status on survival outcomes in metastatic colorectal cancer.

Oğuzhan Yıldız, Hakan Şat Bozcuk, Melek Karakurt Eryılmaz

Pageof 7

Frequent Collaborators

22 joint publications

Melek Karakurt Eryılmaz

20 joint publications

Murat Araz

12 joint publications

Mehmet Zahid Koçak

10 joint publications

Mustafa Karaağaç